Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology Settings
- PMID: 35991694
- PMCID: PMC9386092
- DOI: 10.1016/j.xkme.2022.100508
Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology Settings
Abstract
Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney Health initiative aimed to transform kidney care with goals of decreasing the incidence of kidney failure and increasing the number of patients receiving home dialysis or a kidney transplant. New value-based models of kidney care that specify inclusion of pharmacists as part of the kidney care team were developed to help achieve these goals. To support this Advancing American Kidney Health-catalyzed opportunity for pharmacist engagement, the pharmacy workforce must have a fundamental knowledge of the core principles needed to provide comprehensive medication management to address chronic kidney disease and the common comorbid conditions and secondary complications. The Advancing Kidney Health through Optimal Medication Management initiative was created by nephrology pharmacists with the vision that every person with kidney disease receives optimal medication management through team-based care that includes a pharmacist to ensure medications are safe, effective, and convenient. Here, we propose education standards for pharmacists providing care for individuals with kidney disease in the outpatient setting to complement proposed practice standards.
Keywords: Chronic kidney disease; comprehensive medication management; education standards; nephrology; pharmacist; practice standards.
© 2022 The Authors.
Figures
References
-
- US renal data system . National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda: 2020. USRDS 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States.
-
- Sommer J., Seeling A., Rupprecht H. Adverse drug events in patients with chronic kidney disease associated with multiple drug interactions and polypharmacy. Drugs Aging. 2020;37(5):359–372. - PubMed
-
- Alruqayb W.S., Price M.J., Paudyal V., Cox A.R. Drug-related problems in hospitalised patients with chronic kidney disease: a systematic review. Drug Saf. 2021;44(10):1041–1058. - PubMed
LinkOut - more resources
Full Text Sources
